Skip to main content
BMC Cardiovascular Disorders logoLink to BMC Cardiovascular Disorders
. 2024 Mar 2;24:134. doi: 10.1186/s12872-024-03801-6

Correction to: Effect of sacubitril valsartan on heart failure with mid-range or preserved ejection fraction in patients on maintenance hemodialysis: real-world experience in a single-center, prospective study

Xiao-mei Huang 1,✉,#, Jing-jing Li 2,#, Wang Yin 1,#, Hui-ling Fu 1, Fen Yu 2, Lian-qing Gu 1, Yi Zhang 2, Min Du 3, Zheng Ye 1, Li Xu 1,
PMCID: PMC10908153  PMID: 38431576

Correction to: BMC Cardiovascular Disorders (2024) 24:1

10.1186/s12872-024-03744-y.

Following publication of the original article [1], author Li Xu also should have been denoted as a corresponding author.

The original article has been corrected.

Footnotes

The online version of the original article can be found at 10.1186/s12872-024-03744-y.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Xiao-mei Huang, Jing-jing Li, Wang Yin contributed equally to the article.

Contributor Information

Xiao-mei Huang, Email: huangxiaomei202208@126.com.

Li Xu, Email: magicxxx@163.com.

References

  • 1.Huang X, Li J, Yin W, et al. Effect of sacubitril valsartan on heart failure with mid-range or preserved ejection fraction in patients on maintenance hemodialysis: real-world experience in a single-center, prospective study. BMC Cardiovasc Disord. 2024;24:79. doi: 10.1186/s12872-024-03744-y. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Cardiovascular Disorders are provided here courtesy of BMC

RESOURCES